Development

Mental retardation

  • Mental retardation depends on low intelligence quotient (IQ <70, <2SD from mean) and difficulties in adaptive functioning
  • Mild mental retardation IQ 50-70
  • Moderate/severe mental retardation IQ <50
  • ~ 2% population has MR
  • 1.4 M : 1 F

 

Measures of intellectual, neurodevelopmental, and behavioural progress

  • Developmental tests:
    • Bayley scales of infant development
      • 2nd edition
        • Mental development index (MDI)
        • Psychomotor development index (PDI)
      • 3rd edition
        • Cognitive, language, and motor scales
      • Standardized for 1-42 months
      • Mean = 100, SD = 15
    • Bayley Infant Neurodevelopmental screen (BINS)
      • Standardized for 3-24 months
    • Denver developmental screening test
      • Standardized for birth to 6 years
      • Inventory tests personal-social, language, fine motor-adaptive, and gross motor
  • Intelligence/cognitive tests:
    • Wechsler intelligence scale for children (WISC-IV)
      • 6-17 years
    • Wechsler preschool and primary scale of intelligence (WPPSI-III)
      • 2.5-7.3 years
    • Standford-Binet Intelligence Scales (SB5)
      • 2-85 years
    • Differential Ability Scales (DAS)
    • Leiter International Performance Scale (Leiter-R)
    • Comprehensive Test of Nonverbal Intelligence (CTONI)
  • Neuropsychological tests:
    • NEPSY (NEuro and PSYchology)
    • Delis-Kaplan Executive Function System (D-KEFS)
  • Indirect functional ratings by parent/caregiver
    • Vineland Adaptive Behaviour Scales (Vineland-II)
    • Infant Development Inventory
    • Child Development Inventory
  • Domain-specific developmental measures:
    • Motor profile:
      • Alberta Infant Motor Scale (AIMS)
      • Peabody Developmental Motor Scale (PDMS)
    • Language skills:
      • Peabody Picture Vocabulary Test (PPVT-R)
    • Behaviour and ADLs:
      • Vineland Adaptive Behaviour Scales (Vineland-II)
      • Pediatric Evaluation of Disability Inventory (PEDI)
      • Pediatric Functional Independent Measure (WeeFIM)

 

Goodenough Draw-a-Person Test

  • Administered to age 3-15 years
  • Told to draw a man, a woman, and themselves
  • Score = 3 + a/4 where a = each feature recorded in the picture

 

Genetic causes of mental retardation

  • X-linked disorders:
    • Fragile X syndrome
      • FMR1 gene, CGG repeat expansion
        • >200 copies – Fragile X syndrome
        • 55-200 copies – Fragile X-associated tremor/ataxia syndrome (FXTAS)
      • FMR protein involved in protein translation in dendrites
      • Long, narrow face, large protruding ears, macroorchidism, joint laxity
      • 20% have epilepsy
    • Many other X-linked disorders, including ARX, MECP2
  • Chromosomal disorders:
    • Trisomy 21
    • Prader-Willi syndrome
    • Williams’ syndrome
  • Other single-gene mutations:
    • Rubinstein-Taybi
    • Coffin-Lowry
    • Oligophrenin (ORHN1)
    • FMR2
  • Metabolic disorders:
    • PKU
    • Galactosemia
    • Smith-Lemli-Opitz

 

Acquired causes of mental retardation

  • Prenatal:
    • Fetal alcohol syndrome, other maternal substance abuse
    • Nutritional (materal PKU, iodine deficiency)
    • Infection (rubella, toxoplasmosis, CMV, HIV)
    • Stroke
  • Perinatal:
    • Birth asphyxia
    • Infection (HSV encephalitis, GBS meningitis)
    • Stroke
    • SGA, prematurity
    • Hypoglycemia, hyperbilirubinemia
  • Postnatal/environmental:
    • Toxins (lead)
    • Infection (H. flu b meningitis, arbovirus encephalitis)
    • Stroke
    • Trauma and NAI
    • Poor nutrition, poverty

 

High-yield tests if no hints to diagnosis

  • Karyotype with high-resolution banding
  • Fragile X mental retardation (FMR1) testing
  • MRI brain

 

 

Cognitive syndromes

 

Symptom

Features

Localization

Aphasia

     Sensory (Wernicke)

 

 

     Motor (Broca’s)

 

     Conduction aphasia

 

Phonetic errors, phonemic errors, paraphasias

 

Decreased production and fluency

 

Poor repetition, normal fluency

 

Dominant posterosuperior temporal gyrus

 

Dominant inferior frontal gyrus

 

Dominant arcuate fasciculus

Alexia with agraphia

 

Dominant supramarginal and angular gyri

Dysprosody

Impaired discrimination, production, repetition of intonation/melody/phrasing

Nondominant perisylvian cortex

Agnosia

     Visual

 

 

     Tactile

 

     Auditory

 

     Spatial

 

Achromatopsia, visual object agnosia, prosopagnosia

 

Astereognosis

 

Word deafness, amusia

 

Extinction, neglect

 

Bilateral occipitaotemporal visual association cortex

 

Contralateral parietal cortex

 

Bilateral temporoparietal cortex

 

Nondominant parietal cortex

Apraxia

     Ideational

 

     Ideomotor

 

 

     Limb-kinetic

 

Inability to perform learned motor skills

 

Inability to copy gestures or use tools

 

 

Loss of finger dexterity

 

Dominant inferior parietal cortex

 

Contralateral and dominant premotor and supplementary motor cortex

 

Contralateral motor cortex

Gerstmann’s syndrome

Dysgraphia, dyscalculia, right-left disorientation, finger agnosia

Dominant angular gyrus of parietal lobe

 

Attention-Deficit-Hyperactivity Disorder

 

Either “inattention” or “hyperactivity-impulsivity”.

Symptoms present before age of 7 years.

Impairment from symptoms in 2+ settings (school, work, home)

Clear evidence of clinically significant impairment in social, academic, or occupational function.

 

Inattention – 6+ symptoms persistent >6 months that is maladaptive and inconsistent with developmental level

  • Often fails to give close attention to details or makes careless mistakes in schoolwork, work or other
  • Often has difficulty sustaining attention in tasks or play
  • Often does not seem to listen when spoken to directly
  • Often does not follow through on instructions and fails to finish schoolwork, chores, work duties
  • Often has difficulty organizing tasks or activities
  • Often avoids, dislikes, or is reluctant to engage in tasks that require sustained mental effort
  • Often loses things necessary for tasks or activities
  • Often easily distracted by extraneous stimuli
  • Often forgetful in daily activities

 

Hyperactivity-impulsivity – 6+ symptoms for >6 months that is maladaptive and inconsistent with dev level

  • Often fidgets with hands or feet or squirms in seat
  • Often leaves seat in classroom or other situation where sitting is expected
  • Often runs about or climbs excessively where inappropriate (or feelings of restlessness or adults)
  • Often has difficulty playing or engaging in leisure activities quietly
  • Often “on the go” or acts as if “driven by a motor”
  • Often talks excessively
  • Often blurts out answers before questions have been completed
  • Often has difficulty awaiting turn
  • Often interrupts or intrudes on others (butts into conversations or games)

 

Drug

mg/kg/day

Dosing

Side effects & comments

STIMULANTS

 

Dextromamphetamine

- Dexedrine

 

0.3-1.0

 

bid-tid

 

Insomnia, anorexia, depression, psychosis, high HR/BP, FTT, withdrawal effects, rebound phenomena

L&D amphetamine

- Adderall

 

0.5-1.5

 

qd-bid

 

Methylphenidate

- Ritalin

 

1.0-2.0

 

bid-tid

 

 

Mg pemoline

- Cylert

 

1.0-2.5

 

qd-bid

 

Rare, serious hepatotoxicity (check LFTs)

LONG-ACTING STIMULANTS

 

Methylphenidate

- Concerta

- Ritalin LA

 

1.0-2.0

 

qd-bid

 

 

L&D amphetamine

- Adderall XR

 

0.5-1.5

 

qd-bid

 

SNRIs

 

Atomoxetine

- Strattera

 

0.5-1.4

 

qd-bid

 

Mild anorexia, GI symptoms, mild high BP/HR. Jaundice, high LFTs, suicidal thinking

May be helpful with comorbid enuresis, tics, mood disorders

 

TCAs (imipramine, amitryptyline). SSRIs (fluoxetine, citalopram), Buproprion, Venlafaxine for ADHD and comorbid tics, OCD, mood disorders.

 

Alpha-agonist (clonidine) for tics, ADHD, aggression, agitation, withdrawal.

 

Beta-blockers (propranolol) for aggression, agitation, akathisia.

 

Nonpharmacological therapies include:

  • Mimization of distractions (front row, uncluttered desk, minimal distractions)
  • Structure, organization techniques (checklists, homework assignment pads)
  • Biofeedback, complimentary/alternative therapies

Tic disorders

 

Transient tic disorder – duration of tics <1 year

Chronic tic disorder – duration of tics >1 year of one type (motor, vocal)

 

Tourette syndrome – diagnostic criteria

  • Multiple motor and at least one vocal tic
  • Waxing and waning course
  • Onset before age 21 years
  • No precipitating illness or medication

 

Features of Tourette syndrome

  • 3M : 1F
  • Mean onset 6-7 years
  • Soft neurological signs of coordination and fine motor difficulties, synkinesis, restlessness
  • Often associated with other neuropsychiatric disorders, e.g., OCD, ADHD, depression/anxiety, episodic rage/self-injurious behaviour, academic difficulties, executive dysfunction.

 

PANDAS – Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal infection

  • Prepubertal onset
  • Tic disorder or obsessive-compulsive disorder
  • Acute fulminant onset
  • Associated with group A beta-hemolytic streptococcal infusion
  • Associated with neurological abnormalities

 

Nonpharmacological therapies:

  • Behavioural treatments (habit reversal training, support groups, relaxation therapy)
  • Acupuncture

 

Pharmacological therapies:

  • Tier 1 medications (milder tics)
    • Clonidine
    • Guanfacine
    • Baclofen
    • Clonazepam
    • Others: gabapentin, topiramate, levetiracetam
  • Tier 2 medications (more severe tics)
    • Typical and atypical neuroleptics
    • Pimozide, fluphenazine, risperidone, olanzapine, haloperidol, etc
    • Pergolide, donepezil
    • Botulinum toxin, nicotine patch, delta-9-tetrahydrocannabinol (special cases)
  • Experimental:
    • Transcranial magnetic stimulation
    • Deep brain stimulation

 

Goal is to minimize tics’ to limit psychosocial effects, not completely rid of tics.

 

Autistic spectrum disorders

Pervasive developmental disorders

  • Autistic disorder
  • Asperger’s disorder
  • Childhood disintegrative disorder
  • Rett’s disorder
  • PDD-NOS

 

Autistic disorder (DSM-IV criteria)

  • 6+ items
    • Impaired social interaction (2+ of these)
      • Impaired nonverbal behaviors (eye gaze, facial expression, body posture, gestures
      • Failure to develop appropriate peer relationships
      • Lack of spontaneous seeking to share enjoyment, interests, achievements with others
      • Lack of social or emotional reciprocity
    • Impaired communication (1+ of these)
      • Delayed language (including gestures)
      • Impaired ability to initiate or sustain conversation
      • Stereotyped/repetitive language or idiosyncratic language
      • Lack of varied, spontaneous make-believe or appropriate social imitative play
    • Restrictive repetitive and stereotypic patterns of behaviour, interests, activities:
      • Preoccupation with stereotyped or restricted patterns of interest
      • Inflexible adherence to nonfunctional routines/rituals
      • Stereotyped/repetitive motor mannerisms (hand flapping, twisting movements)
      • Preoccupation with parts of objects
  • Delayed/abnormal function in 1+ of these areas before age 3 years:
    • Social interaction
    • Language in social communication
    • Symbolic/imaginative play
  • Not Rett’s or childhood disintegrative disorder

 

Asperger’s disorder

  • Normal IQ (no language delay), normal self-help skills, curiosity about environment
  • Impairments in social interaction and restrictive/repetitive patterns of behaviour/actiivites
  • Difficulty forming friendships due to naïve, inappropriate, one-sided social interactions, lack of empathy
  • Desire success in interpersonal relationships and are puzzled by the failure
  • Discrepant verbal & nonverbal IQ scores (as opposed to in autism)

 

Childhood disintegrative disorder

  • Rare
  • Normal early development
  • Neurodevelopmental regression after 24 months, leading to autistic symptoms
  • Onset from 3-10 years (usually 3-4 years)
  • Profound cognitive regression to mental retardation
  • 4M : 1F

 

Rett’s syndrome

  • X-linked dominant, male lethal – MECP2 – methyl-CpG-binding protein 2 – regulates gene expression
  • Neurodegenerative disorder, usually females, onset after period of normal development
  • Reduced life expectancy (70% survive to 35 years)
  • Must have had:
    • Normal prenatal/perinatal development
    • Normal psychomotor development until 5 months age
    • Normal birth head circumference
  • Onset of these after period of normal development:
    • Decelerated head growth from 5-48 months
    • Loss of purposeful hand skills, development of stereotyped hand movements
    • Loss of social engagement early on (interaction often develops later)
    • Poorly coordinated gait/trunk movements
    • Severely impaired expressive/receptive language, severe psychomotor retardation
  • Symptoms later become relatively static
  • Inconsolable crying, screaming, agitation, food refusal
  • Breathing irregularities
    • Periodic apnea during wakefulness
    • Intermittent hyperventilation
  • Seizures, EEG abnormalities
  • Scoliosis, growth retardation, small feet
  • Atypical Rett syndrome
    • XY – severe epileptic encephalopathy
    • XXY – classic Rett phenotype
    • XY – mental retardation
    • XX – classic autistic disorder

 

Screening tests for ASD:

  • Checklist for Autism in Toddlers
  • Screening Tool for Autism in Two-year-Olds
  • Pervasive Developmental Disorders Screening Test (PDDST-II)
  • Social Communication Questionnaire

 

Diagnostic tests for ASD:

  • Childhood Autism Rating Scale (good clinical tool)
  • Autism Diagnostic Interview-Revised (ADI) – gold standard
  • Autism Diagnostic Observation Schedule-General (ADOS) – gold standard

 

Investigations in ASD:

  • Auditory testing or ABRs
  • Lead level if pica
  • Metabolic testing only if other clinical or physical signs
  • Neuroimaging not needed in autism and macrocephaly

 

Coexisting medication disorders:

  • Feeding and GI problems
  • Sleep disturbances
  • Epilepsy
  • Mitochondrial disorders
  • PKU
  • Fragile X
  • Tuberous sclerosis complex
  • Neurofibromatosis
  • Prader-Willi syndrome
  • Angelman syndrome
  • Smith-Lemli-Opitz syndrome

 

Psychiatry and nonorganic disorders

 

Somatiform disorders

  • Symptoms linked to psychological factors, but not under voluntary control or consciously produced
  • Conversion disorder – psychological factors primary role
  • Somatization disorder – recurrent, multiple complaints over many years, unrelated to physical disorder

 

Factitious disorder – intentionally produced due to psychological need, often with personality disorder

 

Malingering – voluntary produced physical symptoms in persuit of a goal, e.g, financial, legal